Shufro Rose & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Sell |
39,110
-1,164
| -3% | -$31K | 0.07% | 118 |
|
|
2025
Q4 | $1M | Buy |
40,274
+279
| +0.7% | +$7.04K | 0.07% | 119 |
|
|
2025
Q3 | $1.01M | Sell |
39,995
-1,000
| -2% | -$24.7K | 0.08% | 118 |
|
|
2025
Q2 | $1.04M | Hold |
40,995
| – | – | 0.08% | 116 |
|
|
2025
Q1 | $1.04M | Sell |
40,995
-2,500
| -6% | -$65.4K | 0.08% | 116 |
|
|
2024
Q4 | $1.15M | Sell |
43,495
-9,802
| -18% | -$266K | 0.09% | 106 |
|
|
2024
Q3 | $1.49M | Hold |
53,297
| – | – | 0.12% | 96 |
|
|
2024
Q2 | $1.49M | Sell |
53,297
-9,141
| -15% | -$252K | 0.12% | 96 |
|
|
2024
Q1 | $1.73M | Sell |
62,438
-9,308
| -13% | -$258K | 0.14% | 84 |
|
|
2023
Q4 | $2.38M | Sell |
71,746
-400
| -0.6% | -$12.1K | 0.23% | 61 |
|
|
2023
Q3 | $2.39M | Sell |
72,146
-1,798
| -2% | -$63.6K | 0.23% | 61 |
|
|
2023
Q2 | $2.71M | Buy |
73,944
+1,519
| +2% | +$59.1K | 0.25% | 56 |
|
|
2023
Q1 | $2.95M | Sell |
72,425
-7,636
| -10% | -$330K | 0.27% | 58 |
|
|
2022
Q4 | $4.1M | Sell |
80,061
-4,869
| -6% | -$233K | 0.35% | 57 |
|
|
2022
Q3 | $3.72M | Buy |
84,930
+487
| +0.6% | +$23.7K | 0.37% | 53 |
|
|
2022
Q2 | $4.43M | Sell |
84,443
-422
| -0.5% | -$21.5K | 0.38% | 55 |
|
|
2022
Q1 | $4.39M | Buy |
84,865
+819
| +1% | +$42.5K | 0.34% | 58 |
|
|
2021
Q4 | $4.96M | Sell |
84,046
-1,059
| -1% | -$52.5K | 0.36% | 57 |
|
|
2021
Q3 | $3.66M | Sell |
85,105
-504
| -0.6% | -$22.3K | 0.29% | 59 |
|
|
2021
Q2 | $3.35M | Sell |
85,609
-798
| -0.9% | -$31K | 0.25% | 58 |
|
|
2021
Q1 | $3.13M | Sell |
86,407
-1,492
| -2% | -$53K | 0.25% | 58 |
|
|
2020
Q4 | $3.24M | Sell |
87,899
-9,425
| -10% | -$346K | 0.27% | 61 |
|
|
2020
Q3 | $3.39M | Buy |
97,324
+7,070
| +8% | +$248K | 0.33% | 53 |
|
|
2020
Q2 | $2.8M | Sell |
90,254
-926
| -1% | -$31.5K | 0.28% | 60 |
|
|
2020
Q1 | $2.82M | Sell |
91,180
-13,094
| -13% | -$446K | 0.34% | 54 |
|
|
2019
Q4 | $3.88M | Sell |
104,274
-840
| -0.8% | -$29.9K | 0.35% | 55 |
|
|
2019
Q3 | $3.58M | Sell |
105,114
-1,002
| -0.9% | -$36.4K | 0.35% | 59 |
|
|
2019
Q2 | $4.36M | Sell |
106,116
-737
| -0.7% | -$29.3K | 0.42% | 54 |
|
|
2019
Q1 | $4.31M | Sell |
106,853
-2,132
| -2% | -$85.4K | 0.43% | 54 |
|
|
2018
Q4 | $4.51M | Sell |
108,985
-1,969
| -2% | -$81.7K | 0.5% | 53 |
|
|
2018
Q3 | $4.64M | Sell |
110,954
-105
| -0.1% | -$4.04K | 0.43% | 64 |
|
|
2018
Q2 | $3.82M | Sell |
111,059
-2,632
| -2% | -$89.9K | 0.37% | 71 |
|
|
2018
Q1 | $3.83M | Sell |
113,691
-4,575
| -4% | -$157K | 0.38% | 65 |
|
|
2017
Q4 | $4.06M | Sell |
118,266
-383
| -0.3% | -$13.1K | 0.4% | 61 |
|
|
2017
Q3 | $4.02M | Sell |
118,649
-342
| -0.3% | -$11K | 0.4% | 60 |
|
|
2017
Q2 | $3.79M | Sell |
118,991
-1,511
| -1% | -$47.7K | 0.41% | 59 |
|
|
2017
Q1 | $3.91M | Sell |
120,502
-1,383
| -1% | -$43.6K | 0.42% | 57 |
|
|
2016
Q4 | $3.76M | Sell |
121,885
-36
| -0% | -$1.1K | 0.42% | 57 |
|
|
2016
Q3 | $3.92M | Buy |
121,921
+968
| +0.8% | +$32.4K | 0.44% | 58 |
|
|
2016
Q2 | $4.04M | Sell |
120,953
-1,761
| -1% | -$56.2K | 0.45% | 59 |
|
|
2016
Q1 | $3.45M | Sell |
122,714
-138
| -0.1% | -$3.94K | 0.39% | 65 |
|
|
2015
Q4 | $3.76M | Sell |
122,852
-501
| -0.4% | -$15.8K | 0.43% | 65 |
|
|
2015
Q3 | $3.68M | Sell |
123,353
-3,004
| -2% | -$96.3K | 0.44% | 59 |
|
|
2015
Q2 | $4.02M | Sell |
126,357
-2,255
| -2% | -$73.5K | 0.43% | 62 |
|
|
2015
Q1 | $4.25M | Sell |
128,612
-158,629
| -55% | -$5.04M | 0.44% | 65 |
|
|
2014
Q4 | $8.49M | Sell |
287,241
-55,999
| -16% | -$1.61M | 0.86% | 41 |
|
|
2014
Q3 | $9.63M | Sell |
343,240
-1,581
| -0.5% | -$44.4K | 1% | 35 |
|
|
2014
Q2 | $9.71M | Sell |
344,821
-4,754
| -1% | -$136K | 1% | 33 |
|
|
2014
Q1 | $10.7M | Sell |
349,575
-18,413
| -5% | -$549K | 1.12% | 28 |
|
|
2013
Q4 | $10.7M | Sell |
367,988
-6,728
| -2% | -$196K | 1.13% | 26 |
|
|
2013
Q3 | $10.2M | Sell |
374,716
-35,705
| -9% | -$971K | 1.16% | 27 |
|
|
2013
Q2 | $10.9M | Buy |
+410,421
| New | +$11.3M | 1.3% | 23 |
|
Other funds holding PFE
VCM
VPM
Shufro Rose & Co's PFE Position: Q1 2026 in Review
Shufro Rose & Co reduced its Pfizer (PFE) stake by 2.9% in Q1 2026, selling an estimated $31K and leaving 39,110 shares worth $1.1M. The position accounts for 0.07% of the portfolio, ranked #118.
Shufro Rose & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.9M in Q2 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Shufro Rose & Co held 39,110 shares of Pfizer worth $1.1M as of Q1 2026.
- Shufro Rose & Co sold 1,164 Pfizer shares in Q1 2026, an estimated $31K.
- Pfizer made up 0.07% of Shufro Rose & Co's portfolio in Q1 2026, its #118 holding.
- Shufro Rose & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Shufro Rose & Co's Pfizer position peaked at $10.9M in Q2 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.